Battles still rage over the WHI's findings

Brown, Simon
September 2007
Menopause International;Sep2007, Vol. 13 Issue 3, p92
Academic Journal
The article focuses on the controversy arising from the Women's Health Initiative (WHI) report in which investigators studied the heart risks of menopausal hormones in July 2002. The "Wall Street Journal" alleged that the study's own investigators and physicians were excluded by officials from the National Institutes of Health (NIH) in its review of the report. The WHI report was also criticized by Doctor Robert Rebar of the American Society for Reproductive Medicine (ASRM), who emphasized that it is dangerous to recommend hormone therapy to all patients.


Related Articles

  • Consenso de la Asociación Mexicana para el Estudio del Climaterio para la indicación de veraliprida a pacientes con síntomas vasomotores. Basavilvazo-Rodríguez, Antonia; Bravo-Rodríguez, Luz María; Carranza-Lira, Sebastián; Celis-González, Cuauhtémoc; Hernández Marín, Imelda; Hernández-Valencia, Marcelino; López Navarro, María Elena; de Dios Maldonado Alvarado, Juan; Montaño U., J. Armando; Moreno Avellán, Álvaro José; Vázquez, Gumersindo // Ginecologia y Obstetricia de Mexico;Jul2012, Vol. 80 Issue 7, p467 

    Vasomotor symptoms are one of the main reasons for climateric women to consult a physician. Hormone therapy is the first treatment choice, but it is not indicated to all patients. Veralipride is an option for those who cannot or will not try hormone treatment. The Mexican Association for the...

  • Hormone Replacement Therapy cautions.  // Prevention India;Nov2014, p1 

    The article talks about the benefits of Hormone Replacement Therapy (HRT) in preventing osteoporosis in women with premature menopause. Topics discussed include role of HRT in reducing severity of vasomotor symptoms such as hot flushes and night sweats, side effects of HRT such as nausea,...

  • HOW SAFE IS HRT? Hope, Sally // Practice Nurse;4/11/2003, Vol. 25 Issue 7, p32 

    Examines the relative risks and benefits of hormone replacement therapy (HRT). Guidelines on prescribing HRT; Alternatives to HRT; Relative and absolute risks in women taking HRT.

  • Poster presentations.  // Journal of the British Menopause Society;2006, Vol. 12 Issue 4, p201 

    The article primarily presents poster presentations for various diseases and the therapeutic procedures available. The progestin therapy used in the study and treatment of tibolone with a low-dose continuous combined estrogen is presented. The article also presents risk factors and hormone...

  • WSJ launches Latin initiative.  // MediaWeek;9/12/94, Vol. 4 Issue 35, p4 

    Reports on the `Wall Street Journal' newspaper's launching of `The Wall Street Journal Americas,' a Spanish-speaking language business news section; Paper's circulation.

  • Wall Street Journal seeks agency for Euro brand push.  // Marketing Week;12/18/1997, Vol. 20 Issue 38, p9 

    Reports on `Wall Street Journal Europe' newspaper's search for an advertising agency to devise a pan-European brand-building campaign. Response to rival `Financial Times' which launched an American edition; Plans to create press advertisements and posters; Launch of the first British-specific...

  • The European Wall Street Journal. O'Connor, Robert // Editor & Publisher;7/17/93, Vol. 126 Issue 29, p14 

    Features the style and elements of writing of the `Wall Street Journal Europe'. Europeanization of the content of the paper; Adoption and Europeanized regular features appearing in the American version; Usage of color advertising; Partnership with `Handelsblatt,' a German financial daily;...

  • Long-term HRT risks outweigh benefits.  // Pulse;Nov2013, p16 

    The article reports on the follow-up analysis by Women's Health Initiative (WHI) trials which reveals that long-term hormone replacement therapy (HRT) has several health risks including coronary heart disease (CHD), breast cancer, and stroke.

  • Hormone Therapy: The End of an Era.  // Annals of Internal Medicine;4/6/2004, Vol. 140 Issue 7, p540 

    Studies whether hormone therapy improved quality of life for women with coronary heart disease. Assessment of the quality of life with the Duke Activity Status Index questionnaire measuring functional capacity, emotional health, vitality and depression in women; Improvement in the quality of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics